From multiple biomarkers to single insight

Access insights of tumor profile with comprehensive genomic profiling (CGP)

Watch this webinar with Dr. David Eberhard to learn more about how CGP helps your lab provide actionable insights for oncologists and their patients.

With hundreds of biomarkers linked to approved drugs and ongoing clinical trials comes a need for consolidated testing in a single assay. CGP is a powerful assay that:

  • enables simultaneous detection of 500+ oncology biomarkers in a single, next-generation sequencing test.
  • identifies actionable biomarkers that help optimize treatment. In a series of studies, up to 90% of patients had actionable alterations as a result of CGP testing.
  • provides faster results using fewer samples for increased efficiency.

Watch the webinar to learn more

Would you like to receive email marketing communications from Illumina?

 

 

 

 

 

 

By submitting this form, you agree to have your contact information passed along for the purpose of following up on your interests and in order receive communications regarding Illumina products, services, and events. The data sent will be processed in Canada and provided to Illumina who will assume responsibility for processing and Opt-out and Information Removal. For more information, please read our Terms of Use, Privacy, Opt-out & Information Removal.